Skip to main content

Take the CRISPR Call With This Genomics ETF

By: ETFdb
Investors looking for access to CRISPR gene editing technologies should consider the ARK Genomic Revolution Multi-Sector Fund ( ARKG ), one of the ETFs best-positioned in this fast growing arena.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.